Literature DB >> 31365752

Multiple Primary Tumors Over a Lifetime.

Mehmet Sitki Copur, Suresh Manapuram.   

Abstract

The frequency of patients living after a cancer diagnosis continues to increase due to the rising incidence of cancer as well as the improved survival of cancer patients thanks to advances in cancer research and treatment. The risk of multiple primary cancers is also increasing due to increasing numbers of cancer survivors, long-term side effects of chemotherapy and/or radiation therapy, increased diagnostic sensitivity, and persisting effects of genetic and behavioral risk factors. Multiple primary cancers are defined as more than one synchronous or metachronous cancer in the same individual. Although several different definitions of multiple primaries have been proposed, the main definitions come from the Surveillance, Epidemiology, and End Results (SEER) Program and the International Association of Cancer Registries and International Agency for Research on Cancer (IACR/IARC). Depending on the definition, overall reported frequency of multiple primary cancers varies between 2.4% and 17%. Underlying causes for multiple primary cancers may include host and lifestyle-related factors, environmental and genetic factors and treatment related factors. Significant temporal changes have been found in the prevalence of cancer risk factors (ie, smoking, alcohol consumption, obesity) as well as advances in diagnostic sensitivity and improved screening programs that may affect the incidence of second or more cancers. In this review, the literature on multiple primary cancers is analyzed with a focus on clinical situations where a treating physician should take into consideration the possibility of multiple primaries.

Entities:  

Mesh:

Year:  2019        PMID: 31365752

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  18 in total

1.  Systemic treatment for coexisting mucinous urethral adenocarcinoma and prostate adenocarcinoma.

Authors:  Kunihisa Nezu; Teppei Okubo; Manabu Shiraiwa; Yoshihiro Nozawa; Atsushi Kyan
Journal:  IJU Case Rep       Date:  2020-08-02

2.  Synchronous multiple primary tumors in patients with malignant lymphoma: a retrospective study.

Authors:  Yu Yagi; Yusuke Kanemasa; Yuki Sasaki; An Ohigashi; Yuka Morita; Taichi Tamura; Shohei Nakamura; Akihiko Kageyama; Yasushi Omuro; Tatsu Shimoyama
Journal:  BMC Cancer       Date:  2022-06-11       Impact factor: 4.638

3.  Diagnosis of cardiac occupancy as metachronous carcinoma using multimodal imaging: a case report.

Authors:  Zihan Wang; Xiang Xiao; Shuying Lv; Chunyan Li; Hong Jiang
Journal:  BMC Cardiovasc Disord       Date:  2022-05-04       Impact factor: 2.174

4.  Multiple Primary Malignancies With Hypercalcemia Presentation: A Case Report.

Authors:  Sushmitha Diraviam; Asseel Al-Bayati; Oksana Mayovska; Rabhea Chaudhry; Swapnil V Patel
Journal:  Cureus       Date:  2022-04-19

5.  Case Report: Metachronous Quadruple Cancers Including Breast Cancer and Triple Genital Cancer.

Authors:  Jing Bai; Zhaoguang Xie; Li Sun
Journal:  Int J Gen Med       Date:  2020-12-16

6.  Geospatial analysis of multiple cancers in individuals in the US, 2004-2014.

Authors:  Lia C Scott; Tzy-Mey Kuo; Dora Il'yasova; Lee R Mobley
Journal:  Ann Cancer Epidemiol       Date:  2021-03-30

7.  Second Primary Lung Adenocarcinoma After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma.

Authors:  Fen Xue; Xiaoshuang Niu; Chaosu Hu; Xiayun He
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

8.  Incidence and Survival of Multiple Primary Cancers in US Women With a Gynecologic Cancer.

Authors:  Logan Corey; Julie Ruterbusch; Ron Shore; Martins Ayoola-Adeola; Michael Baracy; Alex Vezina; Ira Winer
Journal:  Front Oncol       Date:  2022-03-23       Impact factor: 6.244

9.  Survival analysis of patients with primary breast duct carcinoma and lung adenocarcinoma: a population-based study from SEER.

Authors:  Fengyuan Lv; Mingliang Cheng; Liang Jiang; Xiaoping Zhao
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

Review 10.  Synchronous hepatocellular carcinoma and gallbladder adenocarcinoma with neuroendocrine differentiation: a case report and literature review.

Authors:  Yan Xu; Quan-Ning Chen; Hui Wang; Nan-Bin Liu; Bao-Min Shi
Journal:  BMC Surg       Date:  2020-10-20       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.